Trial intelligence / Profile preview

Intravenous amoxicillin dosing and pharmacokinetics in children

NL-OMON32761Recruiting

Sponsor
Canisius-Wilhelmina Hospital
Start
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of amoxicillin in bacterial disease, sponsored by Canisius-Wilhelmina Hospital. Primary endpoints: Amoxicillin half-life during elimination phase, Volume of distribution at steady state and 7 more. Started Dec 2010; status: recruiting.

02

Drugs

amoxicillin
03

Conditions

bacterial disease

Beyond the preview

Go deeper on NL-OMON32761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call